CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.
Blood
; 143(2): 118-123, 2024 Jan 11.
Article
in En
| MEDLINE
| ID: mdl-37647647
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Receptors, Chimeric Antigen
Limits:
Child
/
Humans
Language:
En
Journal:
Blood
Year:
2024
Document type:
Article